ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
ContangoPhil
|
18 |
7.4K |
1 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
18
|
7.4K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change in substantial holding
|
|
ContangoPhil
|
3 |
1.6K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
3
|
1.6K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS to Receive Prepayment of 2023 Research Tax Incentive
|
|
ContangoPhil
|
6 |
2.9K |
1 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS to Receive Prepayment of 2023 Research Tax Incentive
|
|
ContangoPhil
|
6 |
2.9K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS to Receive Prepayment of 2023 Research Tax Incentive
|
|
ContangoPhil
|
6 |
2.9K |
1 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Final Set of Interim Data from PXS-5505 in Myelofibrosis
|
|
ContangoPhil
|
7 |
3.1K |
1 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Application for quotation of securities - PXS
|
|
ContangoPhil
|
1 |
558 |
1 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
1
|
558
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
|
|
ContangoPhil
|
15 |
7.6K |
0 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
15
|
7.6K
|
0
|
|
ASX - By Stock
|
SNT |
It's NOT about the Money
|
|
ContangoPhil
|
0 |
527 |
0 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
0
|
527
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
|
|
ContangoPhil
|
15 |
7.6K |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
15
|
7.6K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ContangoPhil
|
8 |
3.4K |
0 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
8
|
3.4K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation - Quarterly Briefing
|
|
ContangoPhil
|
3 |
1.4K |
1 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
News: PXS Pharmaxis Plans To Commence Trial Of Combination Therapy In 2023
|
|
ContangoPhil
|
9 |
3.8K |
0 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
9
|
3.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
News: PXS Pharmaxis Plans To Commence Trial Of Combination Therapy In 2023
|
|
ContangoPhil
|
9 |
3.8K |
0 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
9
|
3.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Drug Study Published in Nature Communications
|
|
ContangoPhil
|
8 |
3.2K |
0 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Drug Study Published in Nature Communications
|
|
ContangoPhil
|
8 |
3.2K |
0 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Becoming a substantial holder
|
|
ContangoPhil
|
3 |
1.4K |
1 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Drug Study Published in Nature Communications
|
|
ContangoPhil
|
8 |
3.2K |
0 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Pharmaxis firing on all Cylinder
|
|
ContangoPhil
|
5 |
3.2K |
2 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
5
|
3.2K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Application for quotation of securities - PXS
|
|
ContangoPhil
|
2 |
844 |
2 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
2
|
844
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Securities Trading Policy - Updated 10 Feb 2023
|
|
ContangoPhil
|
2 |
1.4K |
0 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
2
|
1.4K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Pharmaxis firing on all Cylinder
|
|
ContangoPhil
|
5 |
3.2K |
1 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
5
|
3.2K
|
1
|
|
ASX - By Stock
|
SNT |
Pharmaxis firing on all Cylinder
|
|
ContangoPhil
|
5 |
3.2K |
0 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
5
|
3.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Application for quotation of securities - PXS
|
|
ContangoPhil
|
4 |
1.5K |
2 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
4
|
1.5K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Application for quotation of securities - PXS
|
|
ContangoPhil
|
4 |
1.5K |
1 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
4
|
1.5K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Appoints Dr Simon Green as Director
|
|
ContangoPhil
|
6 |
2.4K |
1 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
6
|
2.4K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Appoints Dr Simon Green as Director
|
|
ContangoPhil
|
6 |
2.4K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
6
|
2.4K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Appoints Dr Simon Green as Director
|
|
ContangoPhil
|
6 |
2.4K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
6
|
2.4K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Director Appointment/Resignation
|
|
ContangoPhil
|
6 |
1.8K |
0 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
6
|
1.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Director Appointment/Resignation
|
|
ContangoPhil
|
6 |
1.8K |
1 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
6
|
1.8K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
4 cents is possible
|
|
ContangoPhil
|
2 |
1.4K |
0 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
2
|
1.4K
|
0
|
|
ASX - By Stock
|
SNT |
4 cents is possible
|
|
ContangoPhil
|
2 |
1.4K |
0 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
2
|
1.4K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation
|
|
ContangoPhil
|
5 |
2.8K |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
5
|
2.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation
|
|
ContangoPhil
|
5 |
2.8K |
2 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
5
|
2.8K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change of Director's Interest Notice
|
|
ContangoPhil
|
5 |
1.6K |
0 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change of Director's Interest Notice
|
|
ContangoPhil
|
5 |
1.6K |
0 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
5
|
1.6K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Who are the "new" investors?
|
|
ContangoPhil
|
8 |
2.0K |
0 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
8
|
2.0K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ContangoPhil
|
15 |
4.8K |
0 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
15
|
4.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ContangoPhil
|
15 |
4.8K |
1 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
15
|
4.8K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Who are the "new" investors?
|
|
ContangoPhil
|
8 |
2.0K |
2 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
8
|
2.0K
|
2
|
|
ASX - By Stock
|
SNT |
Who are the "new" investors?
|
|
ContangoPhil
|
8 |
2.0K |
0 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
8
|
2.0K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ContangoPhil
|
15 |
4.8K |
0 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
15
|
4.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ContangoPhil
|
15 |
4.8K |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
15
|
4.8K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
ContangoPhil
|
15 |
4.8K |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
15
|
4.8K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
ContangoPhil
|
5 |
1.7K |
0 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
5
|
1.7K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change of Director's Interest Notice
|
|
ContangoPhil
|
7 |
2.2K |
0 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change of Director's Interest Notice
|
|
ContangoPhil
|
7 |
2.2K |
2 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
7
|
2.2K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Receives Aptar Option Exercise Fees of US$5m
|
|
ContangoPhil
|
4 |
1.3K |
1 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
4
|
1.3K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Gary Phillips is now a Director of ALA
|
|
ContangoPhil
|
2 |
714 |
1 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
2
|
714
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Final Director's Interest Notice
|
|
ContangoPhil
|
2 |
867 |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
2
|
867
|
1
|
|